Re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14.
作者信息
Lei Ruobing, Li Yuehuan, Chen Yaolong
机构信息
Chevidence Lab of Child & Adolescent Health, Children's Hospital of Chongqing Medical University, Chongqing, China.
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
出版信息
Eur Urol. 2022 Sep;82(3):e67. doi: 10.1016/j.eururo.2022.04.036. Epub 2022 May 27.
PMID:35644770
Abstract
摘要
相似文献
1
Re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14.回复：卡塔琳娜·拜尔、丽莎·莫里、迈克尔·拉尔达斯等人。更新并整合局限性、局部晚期、转移性和非转移性去势抵抗性前列腺癌的核心结局集：先锋联盟的最新进展。《欧洲泌尿外科杂志》2022年；81卷：503 - 514页。
Eur Urol. 2022 Sep;82(3):e67. doi: 10.1016/j.eururo.2022.04.036. Epub 2022 May 27.
2
Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen's Letter to the Editor re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates.对雷若冰、李悦欢和陈耀龙致编辑的信的回复：关于卡塔琳娜·拜尔、丽莎·莫里斯、迈克尔·拉尔达斯等人的《更新和整合局限性、局部晚期、转移性和非转移性去势抵抗性前列腺癌的核心结局集：先锋联盟的最新进展》。《欧洲泌尿外科杂志》2022年；81卷：503 - 514页。在未来更新中提高前列腺癌核心结局集的方法学质量。
Eur Urol. 2022 Sep;82(3):e68-e69. doi: 10.1016/j.eururo.2022.05.014. Epub 2022 Jun 7.
3
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium.更新和整合局限性、局部晚期、转移性和非转移性去势抵抗性前列腺癌的核心结局集：来自 PIONEER 联盟的更新。
Eur Urol. 2022 May;81(5):503-514. doi: 10.1016/j.eururo.2022.01.042. Epub 2022 Feb 17.
4
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93.回复：华金·马特奥、卡里姆·菲扎齐、西尔克·吉列森等人。《非转移性去势抵抗性前列腺癌的管理》。《欧洲泌尿外科杂志》2019年；75卷：285 - 93页。
Eur Urol. 2020 Mar;77(3):e69. doi: 10.1016/j.eururo.2019.05.030. Epub 2019 May 29.
5
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93.回复：华金·马特奥、卡里姆·菲扎齐、西尔克·吉列森等人。《非转移性去势抵抗性前列腺癌的管理》。《欧洲泌尿外科杂志》2019年；75卷：285 - 93页。
Eur Urol. 2020 Mar;77(3):e67-e68. doi: 10.1016/j.eururo.2019.06.026. Epub 2019 Jul 9.
6
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e114-e115. doi: 10.1016/j.eururo.2020.05.034. Epub 2020 Jun 10.
7
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e118-e119. doi: 10.1016/j.eururo.2020.06.057. Epub 2020 Jul 15.
8
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Nov;78(5):e192. doi: 10.1016/j.eururo.2020.07.031. Epub 2020 Aug 13.
9
Re: Michael T. Schweizer, Xian C. Zhou, Hao Wang, et al. The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2014;66:646-52.回复：迈克尔·T·施韦泽、周先成、王浩等。既往阿比特龙治疗对多西他赛在转移性去势抵抗性前列腺癌男性患者中临床活性的影响。《欧洲泌尿外科杂志》2014年；66卷：646 - 52页。
Eur Urol. 2015 Jun;67(6):e113-e114. doi: 10.1016/j.eururo.2014.12.018. Epub 2014 Dec 17.
10
Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e116-e117. doi: 10.1016/j.eururo.2020.05.036. Epub 2020 Jun 11.
Zotero 插件